组织工程与重建外科杂志 ›› 2023, Vol. 19 ›› Issue (4): 342-.

• • 上一篇    下一篇

脂肪源性间充质干细胞外泌体在大鼠全层皮肤缺损创面愈合中的机制研究

  

  • 出版日期:2023-08-01 发布日期:2023-09-05

 Mechanism research of adipose-derived mesenchymal stem cell-derived exosomes in wound healing of full-thickness skin defect in rats

  • Online:2023-08-01 Published:2023-09-05

摘要:

目的 探究脂肪源性间充质干细胞外泌体(hADSC-Exo)在大鼠全层皮肤缺损创面愈合中的作用机制。方
法 分离并鉴定 hADSC 与 hADSC-Exo。将人真皮微血管内皮细胞(hMECs)分为对照组、200 μg/L 重组人表皮生长
因子处理的阳性对照组与 100 μg/mL hADSC-Exo 处理的 hADSC-Exo 组,通过 CCK-8、划痕实验、血管形成实验,
检测 hMECs 增殖、迁移与血管形成能力。60 只大鼠随机分为对照组、阳性对照组、hADSC 组与 hADSC-Exo 组,每
组 15 只。所有大鼠于背部制备全层皮肤缺损创面,每组分别于大鼠尾静脉注射 200 μL 1×PBS、100 μg/kg 重组人
表皮生长因子、200 μL 约含 1×106 个 hADSC 的 1×PBS、200 μL 含 200 μg hADSC-Exo 的 1×PBS。每组随机保留 3
只大鼠,分别于 0、3、7、10、12 d 拍摄创面图像并计算创面面积。每组其余大鼠随机分为 4 组,每组 3 只,分别
于 3、7、10、12 d 采集未愈合创面组织并制成石蜡切片,HE、Masson 染色观察创面愈合情况,免疫组化检测炎症
与创面愈合相关蛋白表达情况。结果 细胞实验结果显示,与对照组相比,阳性对照组、hADSC-Exo 组细胞增殖活性、
细胞迁移率升高(P<0.05),管腔长度与分支点数量增加(P<0.05);与阳性对照组相比,hADSC-Exo 组细胞增殖活
性、细胞迁移率进一步升高(P<0.05),管腔长度与分支点数量进一步增加(P<0.05)。动物试验结果显示,与对照
组相比,阳性对照组、hADSC 组与 hADSC-Exo 组皮肤创面愈合率、CD206、Ⅰ型胶原蛋白(Collagen Ⅰ)、Collagen Ⅲ、
水通道蛋白 3(AQP3)表达水平升高(P<0.05),肿瘤坏死因子 α(TNF-α)、白细胞介素(IL)-6、CD68、角蛋白
1(KRT1)表达水平与 Collagen Ⅰ /Collagen Ⅲ比例下降(P<0.05),新生表皮组织更为完整,厚度增加,表皮下可
见成纤维细胞增殖,创面新生胶原沉积明显增加 ;与阳性对照组相比,hADSC 组与 hADSC-Exo 组 CD206、Collagen
Ⅰ、Collagen Ⅲ、AQP3 表达水平进一步升高(P<0.05),TNF-α、IL-6、CD68、KRT1 表达水平进一步下降(P<0.05)。
结论 hADSC-Exo 能够增强 hMECs 增殖、迁移、血管生成能力,降低创面炎症反应水平,促进创面细胞增殖、胶
原重塑,加速创面愈合,具有成为皮肤创伤治疗药物的潜力。

关键词:

Abstract:

Objective To explore the mechanism of adipose-derived mesenchymal stem cell-derived exosomes (hADSC-Exo) on wound healing of full-thickness skin defect in rats. Methods hADSC and hADSC-Exo were isolated and identified.
Human microvascular endothelial cells (hMECs) were divided into control group, positive control group (treated with 200 μg/L recombinant human epidermal growth factor) and hADSC-Exo group (treated with 100 μg/mL hADSC-Exo). The proliferation, migration and angiogenesis of hMECs were detected by CCK-8, scratch and angiogenesis experiments. A total of 60 rats were randomly divided into control group, positive control group, hADSC group and hADSC-Exo group, 15 rats in each group. Full-layer
skin defect wounds were prepared on the back of all rats. Each group was injected with 200 μL 1×PBS, 100 μg/kg recombinant
human epidermal growth factor, 200 μL 1×PBS containing 1×106 hADSC and 200 μL 1×PBS containing 200 μg hADSC-Exo, re
spectively. Three rats were randomly reserved in each group. The wound images were taken and the wound area was calculated
on the 0, 3, 7, 10 and 12 days respectively. The rest of the rats in each group were randomly divided into 4 groups, with 3 rats in
each group. The unhealed wound tissues were collected on the 3, 7, 10 and 12 days respectively, and tissue samples were prepared into paraffin sections. HE and Masson staining were used to observe the wound healing. The expression of proteins related
to inflammation and wound healing was detected by immunohistochemistry. Results The results of cell experiment showed
that compared with the control group, the cell proliferation activity, cell migration rate, lumen length and the number of branching points increased in the positive control group and hADSC-Exo group (P<0.05). Compared with the positive control group,
the cell proliferation activity, cell migration rate, lumen length and the number of branching points in hADSC-Exo group were
further increased (P<0.05). The results of animal test showed that compared with the control group, the wound healing rate and
the expression levels of CD206, Collagen Ⅰ , Collagen Ⅲ and Aquaporin 3 (AQP3) in the positive control group, hADSC group
and hADSC-Exo group increased (P<0.05), while the expression levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-6,
CD68, keratin 1 (KRT1) and the ratio of Collagen Ⅰ /Collagen Ⅲ decreased (P<0.05), the new epidermis was more intact and
thicker, the proliferation of fibroblasts and the deposition of new collagen in the wound were significantly increased. Compared
with the positive control group, the expression levels of CD206, Collagen Ⅰ , Collagen Ⅲ and AQP3 in hADSC group and hADSC-Exo group were further increased (P<0.05), while the expression levels of TNF-α, IL-6, CD68, KRT1 were further decreased
(P<0.05). Conclusion hADSCs-Exos can enhance the proliferation, migration and angiogenesis of hMECs, reduce the level of
wound inflammation, promote the proliferation of wound cells, collagen remodeling, and accelerate wound healing, which has the
potential to be used as a treatment drug for skin wounds.

Key words: